AI assistant
IRADIMED CORP — Director's Dealing 2022
Feb 17, 2022
32324_dirs_2022-02-17_2ce25a56-2c62-49f1-8e43-9dceea152b28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2022-02-15
Reporting Person: HAWKINS JAMES B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-15 | Common Stock | A | 9441 | $1.48 | Acquired | 30931 | Direct |
| 2022-02-15 | Common Stock | S | 9441 | $50.222 | Disposed | 21490 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-15 | Stock Options (Right to Buy) | $1.48 | M | 9441 | Disposed | 2023-12-31 | Common Stock (9441) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2: This transaction was executed in multiple trades at prices ranging from $50.20 to $50.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.